Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphoma, T-Cell, Cutaneous | 19 | 2022 | 206 | 4.350 |
Why?
|
Skin | 41 | 2023 | 4353 | 3.110 |
Why?
|
Mycosis Fungoides | 10 | 2023 | 163 | 2.540 |
Why?
|
T-Lymphocyte Subsets | 15 | 2022 | 1837 | 2.180 |
Why?
|
T-Lymphocytes | 28 | 2023 | 10163 | 2.170 |
Why?
|
Skin Neoplasms | 27 | 2023 | 5662 | 2.110 |
Why?
|
Immunologic Memory | 15 | 2022 | 1348 | 2.000 |
Why?
|
CD8-Positive T-Lymphocytes | 17 | 2023 | 4438 | 1.470 |
Why?
|
Psoriasis | 8 | 2017 | 898 | 1.360 |
Why?
|
T-Lymphocytes, Helper-Inducer | 4 | 2018 | 986 | 1.190 |
Why?
|
Skin Diseases | 8 | 2023 | 1065 | 1.050 |
Why?
|
Th17 Cells | 4 | 2017 | 765 | 0.850 |
Why?
|
E-Selectin | 6 | 2013 | 579 | 0.840 |
Why?
|
Facial Transplantation | 2 | 2023 | 226 | 0.830 |
Why?
|
Interleukin-9 | 3 | 2016 | 63 | 0.790 |
Why?
|
Interleukin-13 | 2 | 2013 | 389 | 0.760 |
Why?
|
Receptors, Antigen, T-Cell | 9 | 2023 | 2524 | 0.750 |
Why?
|
Dentate Gyrus | 1 | 2021 | 160 | 0.710 |
Why?
|
T-Lymphocytes, Regulatory | 9 | 2023 | 2986 | 0.700 |
Why?
|
Interleukins | 4 | 2013 | 791 | 0.670 |
Why?
|
Drive | 1 | 2018 | 35 | 0.640 |
Why?
|
Antigens, CD1 | 5 | 2023 | 437 | 0.630 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 1 | 2018 | 56 | 0.620 |
Why?
|
Immunoglobulin E | 1 | 2024 | 1460 | 0.620 |
Why?
|
Monitoring, Immunologic | 1 | 2018 | 100 | 0.610 |
Why?
|
Interleukin-17 | 7 | 2020 | 900 | 0.610 |
Why?
|
Sezary Syndrome | 3 | 2021 | 76 | 0.600 |
Why?
|
Arthritis | 1 | 2022 | 658 | 0.590 |
Why?
|
Aminoquinolines | 3 | 2016 | 109 | 0.560 |
Why?
|
Dermatitis, Atopic | 5 | 2021 | 653 | 0.560 |
Why?
|
Antigen Presentation | 2 | 2021 | 1284 | 0.550 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 8 | 2015 | 906 | 0.510 |
Why?
|
Interferon-gamma | 5 | 2021 | 3199 | 0.490 |
Why?
|
Autoantibodies | 1 | 2022 | 2036 | 0.480 |
Why?
|
Th1 Cells | 3 | 2013 | 1056 | 0.460 |
Why?
|
Interleukin-4 | 2 | 2015 | 1146 | 0.450 |
Why?
|
Autocrine Communication | 1 | 2014 | 171 | 0.440 |
Why?
|
Erythema | 1 | 2014 | 254 | 0.440 |
Why?
|
Interleukin-15 | 3 | 2013 | 184 | 0.440 |
Why?
|
Radiotherapy | 1 | 2019 | 1525 | 0.430 |
Why?
|
Lymphocyte Activation | 10 | 2021 | 5519 | 0.420 |
Why?
|
Carcinoma, Squamous Cell | 5 | 2013 | 4029 | 0.420 |
Why?
|
Paracrine Communication | 1 | 2014 | 276 | 0.420 |
Why?
|
Carcinoma, Merkel Cell | 2 | 2013 | 299 | 0.420 |
Why?
|
Health | 1 | 2015 | 390 | 0.400 |
Why?
|
Th2 Cells | 3 | 2013 | 1049 | 0.400 |
Why?
|
Interleukin-2 | 5 | 2023 | 1887 | 0.390 |
Why?
|
Lipids | 2 | 2023 | 3302 | 0.380 |
Why?
|
Leukemia | 2 | 2016 | 1507 | 0.350 |
Why?
|
Cell Nucleus | 1 | 2018 | 2968 | 0.340 |
Why?
|
Antineoplastic Agents | 7 | 2016 | 13655 | 0.340 |
Why?
|
Disease | 1 | 2015 | 681 | 0.340 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2023 | 3336 | 0.340 |
Why?
|
Imidazoles | 1 | 2015 | 1205 | 0.330 |
Why?
|
Graft Rejection | 2 | 2023 | 4393 | 0.330 |
Why?
|
Dermatitis | 3 | 2019 | 197 | 0.330 |
Why?
|
Immunity, Innate | 5 | 2023 | 2956 | 0.330 |
Why?
|
Humans | 91 | 2024 | 742088 | 0.320 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2022 | 3585 | 0.320 |
Why?
|
Cell Separation | 5 | 2010 | 1749 | 0.320 |
Why?
|
Dermatitis, Contact | 2 | 2023 | 129 | 0.310 |
Why?
|
Myeloid Cells | 1 | 2012 | 804 | 0.300 |
Why?
|
Lymphocytes | 3 | 2023 | 2614 | 0.290 |
Why?
|
Immune System | 4 | 2018 | 804 | 0.290 |
Why?
|
Gene Expression Profiling | 4 | 2021 | 9410 | 0.290 |
Why?
|
Antigens, CD | 7 | 2015 | 4024 | 0.280 |
Why?
|
Antigens, Neoplasm | 7 | 2016 | 1983 | 0.280 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 4 | 2017 | 804 | 0.270 |
Why?
|
Cells, Cultured | 14 | 2020 | 19223 | 0.270 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 2 | 2019 | 341 | 0.270 |
Why?
|
Cell Movement | 9 | 2017 | 5212 | 0.270 |
Why?
|
Tumor Escape | 1 | 2008 | 349 | 0.270 |
Why?
|
Forkhead Transcription Factors | 6 | 2013 | 1613 | 0.260 |
Why?
|
Membrane Glycoproteins | 6 | 2013 | 3769 | 0.260 |
Why?
|
Lung | 2 | 2022 | 9826 | 0.260 |
Why?
|
Genes, T-Cell Receptor beta | 2 | 2018 | 71 | 0.260 |
Why?
|
Mice, Inbred NOD | 5 | 2020 | 1875 | 0.250 |
Why?
|
Mice | 22 | 2022 | 81045 | 0.250 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2012 | 1820 | 0.250 |
Why?
|
Lectins, C-Type | 3 | 2015 | 588 | 0.240 |
Why?
|
Transcription Factors | 4 | 2018 | 12164 | 0.240 |
Why?
|
Keratinocytes | 2 | 2021 | 797 | 0.240 |
Why?
|
Superantigens | 1 | 2023 | 129 | 0.230 |
Why?
|
Inflammation | 5 | 2018 | 10578 | 0.230 |
Why?
|
Nitric Oxide | 1 | 2012 | 2128 | 0.230 |
Why?
|
Receptors, Lymphocyte Homing | 2 | 2018 | 143 | 0.230 |
Why?
|
Staphylococcal Skin Infections | 1 | 2023 | 75 | 0.220 |
Why?
|
Candida albicans | 2 | 2017 | 394 | 0.220 |
Why?
|
PUVA Therapy | 2 | 2021 | 98 | 0.220 |
Why?
|
Mice, SCID | 4 | 2020 | 2715 | 0.220 |
Why?
|
Animals | 26 | 2022 | 168561 | 0.210 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2022 | 9185 | 0.210 |
Why?
|
Colorectal Neoplasms | 1 | 2022 | 6754 | 0.210 |
Why?
|
Lymphoma, T-Cell | 2 | 2022 | 299 | 0.200 |
Why?
|
Transforming Growth Factor beta | 4 | 2014 | 2006 | 0.200 |
Why?
|
Chemokines | 2 | 2022 | 954 | 0.200 |
Why?
|
CD4-Positive T-Lymphocytes | 5 | 2018 | 4379 | 0.200 |
Why?
|
Mucin-1 | 2 | 2017 | 543 | 0.200 |
Why?
|
Anthralin | 1 | 2021 | 5 | 0.200 |
Why?
|
Lymphocyte Count | 2 | 2022 | 792 | 0.200 |
Why?
|
Neurons | 1 | 2021 | 9325 | 0.200 |
Why?
|
Graft vs Host Disease | 3 | 2022 | 2951 | 0.200 |
Why?
|
Photopheresis | 1 | 2021 | 24 | 0.190 |
Why?
|
Antibody Formation | 1 | 2005 | 1402 | 0.190 |
Why?
|
Plasma Cells | 1 | 2024 | 592 | 0.190 |
Why?
|
Fibroblasts | 3 | 2006 | 4143 | 0.180 |
Why?
|
Human papillomavirus 16 | 2 | 2014 | 262 | 0.180 |
Why?
|
Galectin 1 | 2 | 2012 | 131 | 0.180 |
Why?
|
Cell Proliferation | 6 | 2021 | 10472 | 0.180 |
Why?
|
Phototherapy | 1 | 2023 | 377 | 0.180 |
Why?
|
Hemolysin Proteins | 1 | 2020 | 113 | 0.180 |
Why?
|
Cytokines | 7 | 2021 | 7317 | 0.180 |
Why?
|
Membrane Lipids | 1 | 2021 | 248 | 0.180 |
Why?
|
Electrons | 1 | 2021 | 268 | 0.170 |
Why?
|
Cell Differentiation | 4 | 2018 | 11470 | 0.170 |
Why?
|
Flow Cytometry | 7 | 2018 | 5975 | 0.170 |
Why?
|
Immunity, Cellular | 1 | 2005 | 1606 | 0.170 |
Why?
|
Palatine Tonsil | 2 | 1997 | 193 | 0.170 |
Why?
|
Cancer Vaccines | 3 | 2016 | 1021 | 0.170 |
Why?
|
Alopecia Areata | 1 | 2021 | 106 | 0.170 |
Why?
|
Nitric Oxide Synthase Type II | 2 | 2012 | 534 | 0.160 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 2 | 2013 | 310 | 0.160 |
Why?
|
Synovial Membrane | 1 | 2021 | 506 | 0.160 |
Why?
|
Chemokine CXCL12 | 1 | 2021 | 462 | 0.160 |
Why?
|
Uterine Cervical Dysplasia | 2 | 2014 | 385 | 0.160 |
Why?
|
Interleukin-10 | 3 | 2009 | 1200 | 0.160 |
Why?
|
Foreskin | 1 | 2018 | 31 | 0.160 |
Why?
|
Administration, Topical | 3 | 2016 | 688 | 0.160 |
Why?
|
Receptors, CCR4 | 3 | 2006 | 81 | 0.160 |
Why?
|
Natural Killer T-Cells | 1 | 2021 | 315 | 0.150 |
Why?
|
Tenascin | 1 | 1997 | 59 | 0.150 |
Why?
|
Gene Expression Regulation | 4 | 2018 | 12071 | 0.150 |
Why?
|
Immunophenotyping | 3 | 2018 | 1866 | 0.140 |
Why?
|
Feces | 1 | 2022 | 1394 | 0.140 |
Why?
|
Killer Cells, Natural | 2 | 2021 | 2133 | 0.140 |
Why?
|
Skin Transplantation | 1 | 2022 | 1074 | 0.140 |
Why?
|
Coculture Techniques | 2 | 2013 | 1341 | 0.140 |
Why?
|
Receptors, Tumor Necrosis Factor | 2 | 2011 | 595 | 0.140 |
Why?
|
Melanoma | 4 | 2020 | 5462 | 0.140 |
Why?
|
Self Tolerance | 2 | 2007 | 124 | 0.140 |
Why?
|
Receptors, CXCR4 | 1 | 2021 | 726 | 0.140 |
Why?
|
Antigen-Presenting Cells | 2 | 2020 | 969 | 0.130 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2018 | 345 | 0.130 |
Why?
|
Azacitidine | 1 | 2017 | 347 | 0.130 |
Why?
|
Tissue Banks | 1 | 2016 | 183 | 0.130 |
Why?
|
Interleukin-1beta | 1 | 2021 | 972 | 0.130 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2017 | 402 | 0.130 |
Why?
|
Adaptive Immunity | 2 | 2017 | 712 | 0.130 |
Why?
|
Candidiasis | 1 | 2017 | 365 | 0.130 |
Why?
|
Integrin alpha Chains | 1 | 2015 | 97 | 0.130 |
Why?
|
Receptors, Chemokine | 3 | 2006 | 669 | 0.120 |
Why?
|
Receptors, IgG | 1 | 2018 | 582 | 0.120 |
Why?
|
Langerhans Cells | 2 | 2012 | 173 | 0.120 |
Why?
|
Scleroderma, Systemic | 1 | 2018 | 313 | 0.120 |
Why?
|
Kinetics | 1 | 2022 | 6474 | 0.120 |
Why?
|
Bacterial Toxins | 1 | 2020 | 933 | 0.120 |
Why?
|
B-Lymphocytes | 2 | 2024 | 4664 | 0.120 |
Why?
|
Congresses as Topic | 1 | 2019 | 764 | 0.120 |
Why?
|
Repressor Proteins | 3 | 2022 | 3020 | 0.120 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2017 | 3557 | 0.120 |
Why?
|
Dermatitis, Allergic Contact | 1 | 2015 | 104 | 0.120 |
Why?
|
Cytoplasm | 1 | 2018 | 1539 | 0.120 |
Why?
|
Interleukin-23 | 1 | 2015 | 193 | 0.110 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2022 | 5425 | 0.110 |
Why?
|
Immunotherapy | 2 | 2021 | 4414 | 0.110 |
Why?
|
Phenotype | 6 | 2016 | 16331 | 0.110 |
Why?
|
Proteome | 2 | 2020 | 1790 | 0.110 |
Why?
|
Mast Cells | 2 | 2018 | 1544 | 0.110 |
Why?
|
Allergens | 2 | 2018 | 1314 | 0.110 |
Why?
|
Hyaluronic Acid | 1 | 1996 | 489 | 0.110 |
Why?
|
Nitroarginine | 1 | 2012 | 66 | 0.110 |
Why?
|
Aged | 13 | 2021 | 162944 | 0.110 |
Why?
|
Dendritic Cells | 3 | 2009 | 2723 | 0.100 |
Why?
|
Arginase | 1 | 2012 | 79 | 0.100 |
Why?
|
Autoimmunity | 2 | 2010 | 1348 | 0.100 |
Why?
|
Tumor Cells, Cultured | 3 | 2015 | 6313 | 0.100 |
Why?
|
Leukemia, T-Cell | 1 | 2012 | 104 | 0.100 |
Why?
|
Bacteria | 1 | 2022 | 2102 | 0.100 |
Why?
|
Toll-Like Receptor 7 | 2 | 2016 | 172 | 0.100 |
Why?
|
Macrophages | 1 | 2006 | 5655 | 0.100 |
Why?
|
Infant, Newborn | 3 | 2022 | 25575 | 0.100 |
Why?
|
Receptors, CCR2 | 1 | 2012 | 212 | 0.100 |
Why?
|
Glycoproteins | 2 | 2012 | 2260 | 0.100 |
Why?
|
Lymphotoxin-alpha | 1 | 2011 | 96 | 0.100 |
Why?
|
Antigens | 3 | 2012 | 1462 | 0.100 |
Why?
|
Cell Adhesion Molecules | 1 | 1997 | 1599 | 0.100 |
Why?
|
Dermis | 1 | 2012 | 207 | 0.090 |
Why?
|
Lymph Nodes | 3 | 2018 | 3465 | 0.090 |
Why?
|
Nevus, Halo | 1 | 2010 | 6 | 0.090 |
Why?
|
Aged, 80 and over | 7 | 2021 | 57683 | 0.090 |
Why?
|
HLA-DR Antigens | 1 | 2012 | 644 | 0.090 |
Why?
|
Immunity, Mucosal | 1 | 2014 | 491 | 0.090 |
Why?
|
Male | 18 | 2021 | 349538 | 0.090 |
Why?
|
Tumor Burden | 2 | 2013 | 1905 | 0.090 |
Why?
|
Gene Expression | 1 | 2023 | 7790 | 0.090 |
Why?
|
Cell Cycle Proteins | 1 | 2022 | 3444 | 0.090 |
Why?
|
Amino Acid Sequence | 3 | 2017 | 13814 | 0.090 |
Why?
|
L-Selectin | 2 | 2010 | 213 | 0.090 |
Why?
|
Cell Division | 2 | 2009 | 4564 | 0.090 |
Why?
|
Interferons | 1 | 2013 | 704 | 0.090 |
Why?
|
Apoptosis | 4 | 2017 | 9715 | 0.090 |
Why?
|
Female | 23 | 2021 | 379592 | 0.090 |
Why?
|
Prospective Studies | 5 | 2021 | 53187 | 0.090 |
Why?
|
Receptors, CCR6 | 2 | 2006 | 80 | 0.090 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 3 | 2016 | 1038 | 0.090 |
Why?
|
Cell Polarity | 1 | 2012 | 644 | 0.090 |
Why?
|
Vitiligo | 1 | 2010 | 90 | 0.090 |
Why?
|
K562 Cells | 2 | 2021 | 632 | 0.090 |
Why?
|
Immune Tolerance | 2 | 2009 | 2257 | 0.080 |
Why?
|
Pore Forming Cytotoxic Proteins | 1 | 2009 | 130 | 0.080 |
Why?
|
Epidermis | 1 | 2012 | 527 | 0.080 |
Why?
|
Oxidative Stress | 2 | 2017 | 3081 | 0.080 |
Why?
|
Perforin | 1 | 2009 | 168 | 0.080 |
Why?
|
Middle Aged | 13 | 2021 | 213127 | 0.080 |
Why?
|
Skin Physiological Phenomena | 1 | 2009 | 180 | 0.080 |
Why?
|
Models, Immunological | 2 | 2012 | 527 | 0.080 |
Why?
|
Lipid Metabolism | 1 | 2017 | 1887 | 0.080 |
Why?
|
Gene Silencing | 1 | 2015 | 1538 | 0.080 |
Why?
|
Viral Vaccines | 1 | 2014 | 636 | 0.080 |
Why?
|
Vulvar Neoplasms | 1 | 2010 | 272 | 0.080 |
Why?
|
Granzymes | 1 | 2009 | 270 | 0.080 |
Why?
|
Drug Hypersensitivity | 1 | 2016 | 883 | 0.080 |
Why?
|
Endothelial Cells | 2 | 2012 | 3455 | 0.080 |
Why?
|
Ligands | 3 | 2010 | 3293 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 2276 | 0.080 |
Why?
|
Signal Transduction | 4 | 2016 | 23387 | 0.070 |
Why?
|
Neoplasm Proteins | 3 | 2017 | 3691 | 0.070 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2015 | 1158 | 0.070 |
Why?
|
Lymphoma | 1 | 2016 | 1873 | 0.070 |
Why?
|
Glucocorticoid-Induced TNFR-Related Protein | 1 | 2006 | 42 | 0.070 |
Why?
|
Clone Cells | 2 | 2022 | 1692 | 0.070 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2006 | 91 | 0.070 |
Why?
|
Immunologic Surveillance | 1 | 2006 | 93 | 0.070 |
Why?
|
Base Sequence | 1 | 2017 | 12797 | 0.070 |
Why?
|
Arthritis, Rheumatoid | 1 | 2021 | 3695 | 0.070 |
Why?
|
Toll-Like Receptors | 1 | 2009 | 592 | 0.070 |
Why?
|
Clonal Deletion | 1 | 2005 | 79 | 0.070 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2018 | 8425 | 0.070 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2006 | 200 | 0.070 |
Why?
|
Health Status | 1 | 2019 | 4030 | 0.070 |
Why?
|
Interleukin-7 | 1 | 2005 | 142 | 0.060 |
Why?
|
Survival Rate | 1 | 2019 | 12773 | 0.060 |
Why?
|
Caspase 1 | 1 | 2006 | 223 | 0.060 |
Why?
|
Hematoma | 1 | 1990 | 755 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2021 | 62966 | 0.060 |
Why?
|
Case-Control Studies | 4 | 2017 | 21719 | 0.060 |
Why?
|
Endocytosis | 1 | 2009 | 983 | 0.060 |
Why?
|
Paired Box Transcription Factors | 1 | 2005 | 215 | 0.060 |
Why?
|
Transplantation, Heterologous | 1 | 2013 | 2382 | 0.060 |
Why?
|
Dioctyl Sulfosuccinic Acid | 1 | 2004 | 7 | 0.060 |
Why?
|
Adenosine Deaminase | 1 | 2006 | 241 | 0.060 |
Why?
|
Interleukin-18 | 1 | 2006 | 248 | 0.060 |
Why?
|
Vaccinia | 2 | 2017 | 76 | 0.060 |
Why?
|
Herpes Labialis | 1 | 2004 | 29 | 0.060 |
Why?
|
Proteomics | 3 | 2023 | 3618 | 0.060 |
Why?
|
Epitopes | 1 | 2011 | 2569 | 0.060 |
Why?
|
Blood | 1 | 2006 | 598 | 0.060 |
Why?
|
Immunoglobulin G | 2 | 2018 | 4554 | 0.060 |
Why?
|
Escherichia coli Proteins | 1 | 2010 | 1052 | 0.060 |
Why?
|
Peptide Fragments | 1 | 2016 | 5095 | 0.060 |
Why?
|
Enzyme-Linked Immunospot Assay | 2 | 2016 | 130 | 0.060 |
Why?
|
Antigens, Differentiation | 1 | 2006 | 926 | 0.060 |
Why?
|
Staphylococcus | 1 | 2023 | 155 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 4751 | 0.060 |
Why?
|
Macrophage Activation | 1 | 2006 | 558 | 0.060 |
Why?
|
Adult | 9 | 2020 | 213712 | 0.060 |
Why?
|
Peptides | 1 | 2015 | 4392 | 0.050 |
Why?
|
Vaccinia virus | 2 | 2017 | 349 | 0.050 |
Why?
|
Receptors, CCR8 | 1 | 2022 | 27 | 0.050 |
Why?
|
Biopsy | 3 | 2010 | 6756 | 0.050 |
Why?
|
Papillomavirus E7 Proteins | 2 | 2014 | 123 | 0.050 |
Why?
|
Enterotoxins | 1 | 2023 | 368 | 0.050 |
Why?
|
Aging | 1 | 2021 | 8626 | 0.050 |
Why?
|
Cell Survival | 4 | 2017 | 5872 | 0.050 |
Why?
|
HEK293 Cells | 2 | 2021 | 4200 | 0.050 |
Why?
|
Oxidation-Reduction | 2 | 2017 | 2187 | 0.050 |
Why?
|
Enzyme Inhibitors | 1 | 2012 | 3800 | 0.050 |
Why?
|
Autoantigens | 1 | 2005 | 891 | 0.050 |
Why?
|
Chemokines, CC | 1 | 2022 | 291 | 0.050 |
Why?
|
Down-Regulation | 1 | 2008 | 3001 | 0.050 |
Why?
|
Homeodomain Proteins | 2 | 2012 | 2417 | 0.050 |
Why?
|
Receptors, Notch | 1 | 2005 | 739 | 0.050 |
Why?
|
Thymus Gland | 1 | 2005 | 1264 | 0.050 |
Why?
|
Neoplasm Staging | 2 | 2016 | 11001 | 0.050 |
Why?
|
Oncogene Proteins, Viral | 2 | 2014 | 362 | 0.050 |
Why?
|
Young Adult | 2 | 2019 | 56350 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11472 | 0.040 |
Why?
|
Cell Adhesion | 2 | 1997 | 3139 | 0.040 |
Why?
|
Homeostasis | 2 | 2012 | 3335 | 0.040 |
Why?
|
HLA Antigens | 1 | 2005 | 1382 | 0.040 |
Why?
|
Stromal Cells | 2 | 2014 | 1353 | 0.040 |
Why?
|
Leukocytes, Mononuclear | 2 | 2020 | 1835 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39004 | 0.040 |
Why?
|
Neutrophils | 1 | 2012 | 3711 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2011 | 4414 | 0.040 |
Why?
|
Cell Communication | 1 | 2006 | 1619 | 0.040 |
Why?
|
Recurrence | 1 | 2011 | 8333 | 0.040 |
Why?
|
Austria | 1 | 2019 | 201 | 0.040 |
Why?
|
Papillomavirus Infections | 1 | 2010 | 1585 | 0.040 |
Why?
|
Reactive Oxygen Species | 2 | 2017 | 2077 | 0.040 |
Why?
|
Interleukin-6 | 1 | 2008 | 3199 | 0.040 |
Why?
|
Epithelial Cells | 1 | 2010 | 3678 | 0.040 |
Why?
|
Internet | 2 | 2016 | 3062 | 0.040 |
Why?
|
Sweden | 1 | 2021 | 1343 | 0.040 |
Why?
|
Immunocompetence | 1 | 2017 | 137 | 0.040 |
Why?
|
Phospholipids | 1 | 2021 | 781 | 0.040 |
Why?
|
Dermatologic Agents | 1 | 2021 | 274 | 0.040 |
Why?
|
Immunologic Techniques | 1 | 1997 | 218 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2021 | 8621 | 0.040 |
Why?
|
Japan | 1 | 2021 | 1360 | 0.040 |
Why?
|
Cations, Divalent | 1 | 1996 | 166 | 0.040 |
Why?
|
Selectins | 1 | 1996 | 102 | 0.030 |
Why?
|
Hyaluronoglucosaminidase | 1 | 1996 | 133 | 0.030 |
Why?
|
Edetic Acid | 1 | 1996 | 277 | 0.030 |
Why?
|
Rheology | 1 | 1997 | 345 | 0.030 |
Why?
|
Vaccines, Subunit | 1 | 2016 | 168 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2021 | 77098 | 0.030 |
Why?
|
Leukemia, Experimental | 1 | 2016 | 246 | 0.030 |
Why?
|
Vitamin D | 1 | 2009 | 3211 | 0.030 |
Why?
|
Poxviridae | 1 | 2015 | 37 | 0.030 |
Why?
|
Haptens | 1 | 2015 | 166 | 0.030 |
Why?
|
Mice, Inbred C57BL | 4 | 2017 | 21821 | 0.030 |
Why?
|
Blotting, Western | 2 | 2015 | 5180 | 0.030 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2017 | 301 | 0.030 |
Why?
|
Chelating Agents | 1 | 1996 | 380 | 0.030 |
Why?
|
Isoquinolines | 1 | 2016 | 368 | 0.030 |
Why?
|
NADP | 1 | 2015 | 225 | 0.030 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 222 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2021 | 2876 | 0.030 |
Why?
|
Brain | 1 | 2021 | 26343 | 0.030 |
Why?
|
Immunotherapy, Adoptive | 2 | 2013 | 1255 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2016 | 9941 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2017 | 18006 | 0.030 |
Why?
|
Protein Binding | 1 | 2006 | 9387 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2022 | 4771 | 0.030 |
Why?
|
Genes, p53 | 1 | 2016 | 755 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2016 | 380 | 0.030 |
Why?
|
Organ Specificity | 1 | 2018 | 2003 | 0.030 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2015 | 430 | 0.030 |
Why?
|
Pilot Projects | 2 | 2023 | 8297 | 0.030 |
Why?
|
Internationality | 1 | 2019 | 1002 | 0.030 |
Why?
|
Cell Compartmentation | 1 | 2014 | 402 | 0.030 |
Why?
|
Models, Biological | 1 | 2009 | 9581 | 0.030 |
Why?
|
Glutathione | 1 | 2015 | 586 | 0.030 |
Why?
|
Integrins | 1 | 1997 | 845 | 0.030 |
Why?
|
Injections, Intramuscular | 1 | 2014 | 548 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2021 | 14554 | 0.030 |
Why?
|
Radiation Chimera | 1 | 2012 | 223 | 0.030 |
Why?
|
Lymphoid Tissue | 1 | 2014 | 455 | 0.030 |
Why?
|
Biological Transport | 1 | 2017 | 2119 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2016 | 2085 | 0.030 |
Why?
|
Carcinoma, Lewis Lung | 1 | 2012 | 114 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 2015 | 1799 | 0.030 |
Why?
|
Antigens, Surface | 1 | 1996 | 1663 | 0.030 |
Why?
|
Mice, Inbred BALB C | 1 | 2021 | 6382 | 0.030 |
Why?
|
Immunization, Secondary | 1 | 2014 | 340 | 0.030 |
Why?
|
Staphylococcus aureus | 1 | 2020 | 1449 | 0.030 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2012 | 140 | 0.020 |
Why?
|
Random Allocation | 1 | 2016 | 2425 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2012 | 400 | 0.020 |
Why?
|
Adolescent | 1 | 2019 | 85649 | 0.020 |
Why?
|
Cell Membrane | 1 | 2021 | 3744 | 0.020 |
Why?
|
Receptors, Interleukin | 1 | 2012 | 245 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 1996 | 1684 | 0.020 |
Why?
|
Anaphylaxis | 1 | 2018 | 746 | 0.020 |
Why?
|
Necrosis | 1 | 2015 | 1643 | 0.020 |
Why?
|
Vaccination | 2 | 2014 | 3256 | 0.020 |
Why?
|
Chemokine CCL22 | 1 | 2010 | 26 | 0.020 |
Why?
|
Antigenic Variation | 1 | 2011 | 125 | 0.020 |
Why?
|
Integrin alpha4 | 1 | 2010 | 92 | 0.020 |
Why?
|
Immunization | 1 | 2015 | 1255 | 0.020 |
Why?
|
Chemokine CCL21 | 1 | 2010 | 51 | 0.020 |
Why?
|
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 2010 | 97 | 0.020 |
Why?
|
Integrin beta Chains | 1 | 2010 | 121 | 0.020 |
Why?
|
RNA, Messenger | 3 | 2015 | 13029 | 0.020 |
Why?
|
Receptors, CCR7 | 1 | 2010 | 108 | 0.020 |
Why?
|
Cervix Uteri | 1 | 2014 | 591 | 0.020 |
Why?
|
Antigens, Viral | 1 | 2014 | 1034 | 0.020 |
Why?
|
Pigmentation | 1 | 2010 | 148 | 0.020 |
Why?
|
P-Selectin | 1 | 2012 | 600 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2006 | 9274 | 0.020 |
Why?
|
Hypersensitivity | 1 | 2018 | 1093 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2022 | 4147 | 0.020 |
Why?
|
Melanoma, Experimental | 1 | 2012 | 559 | 0.020 |
Why?
|
Hematocrit | 1 | 1990 | 636 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 1996 | 1740 | 0.020 |
Why?
|
Tyrosine | 1 | 2013 | 1460 | 0.020 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2012 | 651 | 0.020 |
Why?
|
Binding Sites | 1 | 1997 | 6115 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2010 | 905 | 0.020 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2010 | 675 | 0.020 |
Why?
|
Fibrin | 1 | 1990 | 506 | 0.020 |
Why?
|
Cell Lineage | 1 | 2016 | 2504 | 0.020 |
Why?
|
Chemotaxis | 1 | 2010 | 607 | 0.020 |
Why?
|
Blood Vessels | 1 | 2013 | 1124 | 0.020 |
Why?
|
Cell Line | 1 | 2021 | 15994 | 0.020 |
Why?
|
Melanocytes | 1 | 2010 | 515 | 0.020 |
Why?
|
Boston | 1 | 2019 | 9305 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9735 | 0.020 |
Why?
|
Piperazines | 1 | 2016 | 2488 | 0.020 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2016 | 1596 | 0.020 |
Why?
|
Receptors, Interleukin-2 | 1 | 2006 | 573 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2906 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2723 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2012 | 2906 | 0.020 |
Why?
|
Ointments | 1 | 2004 | 59 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12242 | 0.020 |
Why?
|
Blood Coagulation | 1 | 1990 | 1126 | 0.010 |
Why?
|
Hemoglobins | 1 | 1990 | 1532 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2012 | 3770 | 0.010 |
Why?
|
Self Medication | 1 | 2004 | 117 | 0.010 |
Why?
|
Interleukin-12 | 1 | 2006 | 579 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 1990 | 35342 | 0.010 |
Why?
|
Transfection | 1 | 2010 | 5892 | 0.010 |
Why?
|
Leukocytes | 1 | 2010 | 2039 | 0.010 |
Why?
|
Neoplastic Stem Cells | 1 | 2010 | 1376 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2010 | 6171 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2017 | 16665 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 18112 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2010 | 6608 | 0.010 |
Why?
|
Research Design | 1 | 2016 | 5979 | 0.010 |
Why?
|
Cohort Studies | 2 | 2014 | 40450 | 0.010 |
Why?
|
Acute Disease | 1 | 1990 | 7141 | 0.010 |
Why?
|
Oxygen | 1 | 1990 | 4169 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2010 | 4455 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 29010 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 40054 | 0.010 |
Why?
|
Disease Progression | 1 | 2012 | 13256 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2004 | 12017 | 0.010 |
Why?
|